GENPREX (GNPX) vs Alaunos Therapeutics, Inc. (TCRT)
GENPREX and Alaunos Therapeutics, Inc. are both Biotechnology companies. GENPREX and Alaunos Therapeutics, Inc. are of similar size ($2.9M and $2.8M). Alaunos Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. Across the 10 metrics below, GENPREX leads on 5 and Alaunos Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | GNPX | TCRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (203.86%) | (185.95%) | (57.72%) |
| Return on assets | (157.40%) | (128.30%) | (49.22%) |
| Return on invested capital | 0.00% | (480.35%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack